The real story behind slow productivity growth, how to get more value from clinical trials, why data quality is key and more.

Behavioral variability is quietly sabotaging clinical trials—but it doesn't have to. Here's how predictive behavioral modeling can improve trial design, reduce dropout, and deliver more inclusive, ...

The CORE-MD (Coordinating Research and Evidence for high-risk Medical Devices) consortium has published new consensus ...

Good morning, ladies and gentlemen, and welcome to aTyr Pharma conference call to review the top line results for the Phase III EFZO-FIT study of efzofitimod in pulmonary sarcoidosis. [Operator ...

Objective The purpose of this article is to share insights from the National Institute for Health and Care Research Clinical Research Network (NIHR CRN) in delivering research for Multiple Long Term ...

The investigational therapy BIIB078 may have failed in clinical testing for ALS because it could not reverse key disease processes.

Patients with differentiated thyroid cancer treated with the GLP-1s showed no increased risk of recurrence over a more than 5 ...

Experts weigh in on the use of real-world evidence (RWE) in pain research, providing recommendations for rigorous study design, analysis, and reporting to ensure data validity and credibility.

Clinical trial participants now expect clinical tools to match the usability of the digital tools they use every day.

Timothy Lai, MD, shares promising one-year results from the SALWEEN study on faricimab for polypoidal choroidal vasculopathy ...

Background The long-acting monoclonal antibody nirsevimab and respiratory syncytial virus (RSV) vaccines became available for prevention of severe RSV-associated disease in 2023. While clinical trials ...

HAS COMMENCED RECRUITMENT IN THIS 36 PARTICIPANT STUDY PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / / Medicus Pharma Ltd. ...